Meeting
2023 ASCO Genitourinary Cancers Symposium
Molecular features and actionable targets for testicular germ cell tumors in a real-world setting.
Authors
Rafael Morales-Grimany
Universidad Central del Caribe, Bayamon, PR
Rafael Morales-Grimany , Cesar Delgado , Fady Baky , Armon Amini , Thomas Gerald , Rohit R Badia , Jacob Taylor , Luke Wang , Juan Javier-Desloges , Vitaly Margulis , Solomon L. Woldu , Amir Salmasi , Fred Millard , Rana R. McKay , Aditya Bagrodia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 430)
DOI
10.1200/JCO.2023.41.6_suppl.430
Abstract #
430
Poster Bd #
M12
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Comparing the somatic, germline, and immune landscapes of upper tract urothelial carcinoma (UTUC) and UC of the bladder (UCB).
First Author: Kit L. Yuen
Poster
2021 Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) in patients with relapsed/refractory germ cell tumors (GCT).
First Author: Reem Akel
Poster
2020 Genitourinary Cancers Symposium
Genomic analysis for potential targetable mutations in relapsed and refractory germ cell tumors.
First Author: Sean Q. Kern
Poster
2018 Genitourinary Cancers Symposium
Refractory testicular pure seminoma (PS) and non-seminomatous(NS) germ cell tumors (GCT): A comprehensive genomic profiling (CGP) study.
First Author: Joseph M Jacob